Evogene Ltd.

EVGN·NASDAQ·$0.71Share Price as of 11/2·$6MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)03/26/26 20-FAnnual report (foreign)03/27/25 20-FAnnual report (foreign)03/28/24 20-FAnnual report (foreign)03/30/23 20-FAnnual report (foreign)03/31/22

Disclosures

6-KForeign issuer report10/28/26 6-KForeign issuer report10/06/26 6-KForeign issuer report09/30/26 6-KForeign issuer report09/28/26 6-KForeign issuer report09/15/26

Prospectuses and Registrations

POS AMPost-effective amendment09/28/26 424B5Prospectus supplement07/17/26 424B5Prospectus supplement06/11/26 424B3Prospectus05/20/26 F-3Shelf registration (foreign)03/26/26

Proxies

No matching filings.

Ownership

Form 3Initial insider ownership10/22/26 Form 3Initial insider ownership10/22/26 SC 13D/ABeneficial ownership (amended)10/06/26 Form 4Insider transaction09/30/26 Form 4Insider transaction09/30/26

Other

EFFECTRequest for effectiveness09/29/26 EFFECTRequest for effectiveness04/15/26 CORRESPCorrespondence with the SEC04/13/26 EFFECTRequest for effectiveness04/03/26 UPLOADLetter from the SEC04/01/26